Influence of MDR1 C3435T, CYP2C19*2 and CYP2C19*3 gene polymorphisms and clinical characteristics on the severity of gastric lesions: a case-control study

J Gastrointestin Liver Dis. 2016 Jun;25(2):258-60. doi: 10.15403/jgld.2014.1121.252.mdr.
No abstract available

Publication types

  • Letter

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B / genetics
  • Biopsy
  • Case-Control Studies
  • Cytochrome P-450 CYP2C19 / genetics*
  • Duodenal Diseases / diagnosis
  • Duodenal Diseases / drug therapy
  • Duodenal Diseases / enzymology
  • Duodenal Diseases / genetics*
  • Endoscopy, Gastrointestinal
  • Fibrinolytic Agents / therapeutic use
  • Gene Frequency
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Helicobacter Infections / microbiology
  • Helicobacter pylori / isolation & purification
  • Humans
  • Phenotype
  • Polymerase Chain Reaction
  • Polymorphism, Single Nucleotide*
  • Risk Factors
  • Romania
  • Severity of Illness Index
  • Stomach Diseases / diagnosis
  • Stomach Diseases / enzymology
  • Stomach Diseases / genetics*
  • Stomach Diseases / therapy

Substances

  • ABCB1 protein, human
  • ATP Binding Cassette Transporter, Subfamily B
  • Fibrinolytic Agents
  • CYP2C19 protein, human
  • Cytochrome P-450 CYP2C19